IRadimed Corporation provided earnings guidance for the full year and fourth quarter 2016 and full year and first quarter 2017. For the full year 2017, the Company expects to report revenue of $23.9 million to $24.3 million, GAAP diluted earnings per share of $0.07 to $0.08 and non-GAAP diluted earnings per share of $0.14 to $0.18. For the first quarter 2017, the Company expects to report revenue of $5.2 million to $5.3 million, GAAP diluted loss per share of $0.01 to $0.02 and non-GAAP diluted earnings per share of $0.00 to $0.01. The company expects that approximately $0.3 million of first quarter 2017 revenue will come from backlog, compared to approximately $3.2 million of first quarter 2016 revenue that came from backlog. The Company also announced that it expects to report revenue of approximately $32.6 million for the full year 2016 and $6.1 million for the fourth quarter 2016. The company expects that approximately $12.5 million and $1.3 million of full year and fourth quarter 2016 revenue, respectively, came from backlog. At December 31, 2016, the company had approximately $1.4 million of backlog remaining and expects that backlog will approximate this level throughout 2017.